Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 22, 2025DrugsOpen Access

Tirofiban in Acute Ischemic Stroke: Mechanistic Rationale, Clinical Advances, and Emerging Therapeutic Strategies

View Full Paper
Ask AI
Bookmark
Share

Authors

YJYong JiangWHWenrui HuangYZYiyang Zhang

Discussion

Loading...

Member takes

Overview

Review summarizes tirofiban's effects on clot formation and ischemic stroke recovery in various patient groups, suggesting therapeutic strategies.

Key Points

  • Tirofiban shows promise in improving outcomes for patients with acute ischemic stroke, especially in high-risk groups.
  • In clinical trials, tirofiban has demonstrated effectiveness in restoring blood flow and enhancing long-term recovery.
  • Assessment of mechanistic action reveals tirofiban's ability to inhibit platelet aggregation and prevent clot formation.
  • Emerging data underline the need for further research on optimal dosing and treatment scenarios for different patient profiles.

Cite This Study

Jiang et al. (2025) studied this question.

synapsesocial.com/papers/68af73567567bf4f94fecb8dhttps://doi.org/10.1007/s40265-025-02222-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched one closely related paper. Consider it for comparative context:

  1. 12018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association2018 · 5,534 citations